The relevance of missing heritability in pharmacogenomics

Clinical Pharmacology and Therapeutics

Volumn 92, Issue 4, 2012, Pages 428-430

  Sadee, W ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; COCAINE; PHENYLTHIOUREA;

ARTICLE; DNA POLYMORPHISM; DRUG DESIGN; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG EXPOSURE; ENVIRONMENTAL FACTOR; EPISTASIS; EXCISION REPAIR; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HEREDITY; HERITABILITY; HUMAN; INTRON; LOSS OF FUNCTION MUTATION; PHARMACODYNAMICS; PHARMACOGENOMICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

ANIMALS; ENVIRONMENTAL EXPOSURE; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHARMACOGENETICS; QUANTITATIVE TRAIT, HERITABLE;

EID: 84866625392     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.116     Document Type: Article

References (5)

1. Zuk, O., Hechter, E., Sunyaev, S.R. & Lander, E.S. the mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA 109, 1193-1198 (2012).
2. Sadee, W. et al. Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Clin. Pharmacol. Ther. 89, 355-365 (2011).
3. Wang, D. et al. Intronic polymorphism in cYP3A4 afects hepatic expression and response to statin drugs. Pharmacogenomics J. 11, 274-286 (2011).
4. Bendesky, A., Tsunozaki, M., Rockman, M.V., Kruglyak, L. & Bargmann, c.I. catecholamine receptor polymorphisms afect decision-making in C. elegans. Nature 472, 313-318 (2011).
5. Lord, C.J. & Ashworth, A. the DNA damage response and cancer therapy. Nature 481, 287-294 (2012).